ReviewFrontiers in oncology2022

Immune Checkpoint Inhibitors for Advanced Hepatocellular Carcinoma: Monotherapies and Combined Therapies.

Tao Ouyang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.